Bagante, Fabio
 Distribuzione geografica
Continente #
EU - Europa 6.492
NA - Nord America 5.443
AS - Asia 3.958
SA - Sud America 647
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 16.629
Nazione #
US - Stati Uniti d'America 5.324
RU - Federazione Russa 2.453
SG - Singapore 1.557
CN - Cina 1.391
GB - Regno Unito 1.224
IT - Italia 725
BR - Brasile 544
DE - Germania 442
HK - Hong Kong 435
IE - Irlanda 405
SE - Svezia 368
FR - Francia 358
VN - Vietnam 202
FI - Finlandia 197
UA - Ucraina 95
TR - Turchia 81
KR - Corea 71
CA - Canada 55
AR - Argentina 46
NL - Olanda 39
MX - Messico 38
IN - India 35
AT - Austria 34
IQ - Iraq 26
JP - Giappone 25
BD - Bangladesh 24
ES - Italia 23
ID - Indonesia 23
PL - Polonia 23
BE - Belgio 21
CZ - Repubblica Ceca 18
ZA - Sudafrica 17
MA - Marocco 16
PK - Pakistan 14
CH - Svizzera 13
CO - Colombia 12
EC - Ecuador 12
RO - Romania 11
CL - Cile 9
SA - Arabia Saudita 9
TG - Togo 9
UZ - Uzbekistan 9
LT - Lituania 8
PE - Perù 8
AZ - Azerbaigian 7
EU - Europa 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
VE - Venezuela 6
AU - Australia 5
BJ - Benin 5
PY - Paraguay 5
SC - Seychelles 5
DO - Repubblica Dominicana 4
EE - Estonia 4
HR - Croazia 4
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
TN - Tunisia 4
UY - Uruguay 4
BH - Bahrain 3
CR - Costa Rica 3
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BB - Barbados 2
ET - Etiopia 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
MW - Malawi 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GR - Grecia 1
Totale 16.615
Città #
Southend 1.100
Moscow 769
Chandler 704
Dallas 635
Singapore 634
Ashburn 449
Hong Kong 435
Dublin 403
Jacksonville 403
Woodbridge 320
Beijing 298
The Dalles 182
Houston 163
Munich 161
Ann Arbor 160
Lawrence 150
Princeton 150
Verona 138
Wilmington 135
New York 116
Helsinki 105
Nanjing 95
Los Angeles 94
Jinan 91
Columbus 81
Shenyang 68
Buffalo 67
Redondo Beach 66
Ho Chi Minh City 64
Tianjin 55
São Paulo 49
Milan 46
Santa Clara 46
Sindelfingen 46
Hebei 42
Hanoi 39
Council Bluffs 37
Ningbo 36
Nanchang 34
Seattle 34
Changsha 33
Redwood City 31
Rome 31
Boardman 28
London 28
Norwalk 28
Zhengzhou 28
Turku 27
Falls Church 26
Guangzhou 26
Taizhou 26
Tokyo 24
Nuremberg 23
Seoul 23
Stockholm 22
Haikou 21
Hangzhou 21
San Francisco 21
Brooklyn 20
Vienna 20
Warsaw 20
Washington 20
Brussels 17
Cambridge 17
Montreal 17
Poplar 17
Taiyuan 17
Atlanta 16
Jiaxing 16
Brno 15
Chicago 15
Bologna 14
Brasília 14
Frankfurt am Main 14
Toronto 14
Biên Hòa 13
Chennai 13
Denver 13
Dong Ket 13
Redmond 13
Campinas 12
Jakarta 12
Lanzhou 12
Manchester 12
Mexico City 12
Belo Horizonte 11
Des Moines 11
Zurich 11
Düsseldorf 10
Fairfield 10
Lappeenranta 10
Phoenix 10
Rio de Janeiro 10
Cagliari 9
Johannesburg 9
Lomé 9
Baghdad 8
Bogotá 8
Boston 8
Chengdu 8
Totale 9.717
Nome #
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 481
'Recurrence of cholangiocarcinoma after surgical treatment: an analysis of modes of occurrence, risk factors, and results of treatment. 308
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 283
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 270
A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) 230
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer 217
Impact of age on short-term outcomes of liver surgery: Lessons learned in 10-years' experience in a tertiary referral hepato-pancreato-biliary center 197
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 188
development of two nomograms for predicting major adverse cardiac events and death in patients admitted to the emergency department with chest pain 187
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 184
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. 183
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. 178
Prognostic value of portal hypertension after surgical resection of HCC in cirrhotic patients 175
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 172
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 170
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. 160
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence 160
Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery 160
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 160
Patterns and prognostic significance of lymph-node dissection for surgical treatment of peri-hilar and intrahepatic cholangiocarcinoma 159
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma 155
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 154
Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System 153
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 152
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma 147
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 145
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 144
Cholangiocarcinoma risk factors and the potential role of aspirin 144
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 141
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma 138
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma 136
Tu1730 A Clinical Score Predicting the Occurence of Liver-Related Complications Following Hepatectomy 136
Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis 134
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis 134
Defining Post Hepatectomy Liver Insufficiency: Where do We stand? 132
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma 132
A machine learning analysis of difficulty scoring systems for laparoscopic liver surgery 130
Primary liver cancer: Prognostic factors and predictive response to therapy 128
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer 127
Surgical Resection Versus Local Ablation for HCC on Cirrhosis: Results from a Propensity Case-Matched Study 125
Central Pancreatectomy: from Open to Minimally Invasive 125
Complications after liver surgery: a benchmark analysis 125
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery 122
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas 121
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis 120
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 119
Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings 118
Integrating Clinical Data and Molecular Profiling of Hepato-Pancreato-Biliary Cancers: a Surgical-pathological Approach 118
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme 118
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma 117
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy 117
Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis 116
Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection 116
Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes 115
Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers 115
Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery 112
Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature 112
The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma 111
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma 111
A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases 110
Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection 108
Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database 108
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation 101
Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma 101
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 99
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification 99
Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery 98
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 98
Neuroendocrine liver metastasis: The chance to be cured after liver surgery 97
Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes 97
A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients 97
Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand? 96
ASO Author Reflections: Minimally Invasive Surgery for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension 96
Nomogram to predict perioperative blood transfusion for hepatopancreaticobiliary and colorectal surgery 95
Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study 95
A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population 94
Infectious complications after surgery for perihilar cholangiocarcinoma: A single Western center experience 93
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery 92
Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma 92
Liver transplantation in patients with liver metastases from neuroendocrine tumors 92
Quality of life after treatment of neuroendocrine liver metastasis 91
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma 90
Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery 90
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment 89
The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis 89
A Multi-Institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma 87
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival 87
Kidney Disease: Improving Global Outcomes Classification of Chronic Kidney Disease and Short-Term Outcomes of Patients Undergoing Liver Resection 87
Variation in Medicare Payments and Reimbursement Rates for Hepatopancreatic Surgery Based on Quality: Is There a Financial Incentive for High-Quality Hospitals? 86
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 85
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent 84
The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample 84
Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer 84
Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma 83
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study 83
A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm 83
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis 82
Surgical Procedures in Health Professional Shortage Areas: Impact of a Surgical Incentive Payment Plan 82
Quality Versus Costs Related to Gastrointestinal Surgery: Disentangling the Value Proposition 82
The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery 81
Totale 13.004
Categoria #
all - tutte 65.250
article - articoli 61.464
book - libri 0
conference - conferenze 2.507
curatela - curatele 0
other - altro 427
patent - brevetti 0
selected - selezionate 0
volume - volumi 852
Totale 130.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 145 18 43 79 30 143 44
2021/2022917 106 165 25 63 28 32 24 75 40 31 43 285
2022/20232.317 181 231 241 359 171 609 26 124 261 20 66 28
2023/20241.129 54 93 105 103 159 195 43 112 6 51 140 68
2024/20253.337 185 217 112 560 213 177 166 201 447 224 277 558
2025/20265.230 691 377 673 1.291 2.089 109 0 0 0 0 0 0
Totale 16.840